Clinical Trials Browser

Phase EARLY_PHASE1 × Cachexia × 90 days × Clear all

NCT06736275 2026-05-15

A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors

Phase EARLY_PHASE1 Recruiting

Cachexia